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Prandial Insulin and the Systemic
Appearance of Meal-Derived Glucose in
People With Type 1 Diabetes
T
he rate of appearance of meal-
derived glucose is determined by a
variety of factors. Ingested complex
carbohydrates require enzymatic diges-
tionintomonosaccharidesbeforeabsorp-
tion. Although this step per se is not rate
limiting, the rate of gastric emptying and
orocecal transit time may affect the rapid-
itywithwhichsuchcarbohydratesareex-
posed to the appropriate digestive
enzymes (1). The resulting monosaccha-
ridesarethentransportedintotheentero-
cyte and then into the portal vein where,
ultimately, a fraction is extracted by the
liver. The remainder is released into sys-
temic circulation via the hepatic venous
system. Hepatic extraction of meal-
derived glucose is largely dependent on
the prevailing glucose and, to a lesser ex-
tent, insulin concentrations.
Intriguingly, in this issue of Diabetes
Care,Pennantetal.(2)reportthattherate
of meal-derived glucose appearance in
people with type 1 diabetes is unchanged
by administration of prandial insulin 20
min before meal ingestion. This is a ﬁnd-
ingthatatfacevaluemighthaveprofound
implications for affected patients treated
with intensive insulin therapy.
There is limited information on
splanchnic extraction in type 1 diabetes.
Nuclear magnetic resonance spectros-
copy has demonstrated that in people
with poorly controlled type 1 diabetes,
glycogen synthesis is markedly impaired
after ingestion of a mixed meal (3).
On the other hand, a similar series of
experiments under hyperinsulinemic-
euglycemic conditions concluded that
there was no difference in hepatic glyco-
gen synthesis between people with well-
controlled type 1 diabetes and healthy
control subjects (4).
The applicability of these experi-
ments to the splanchnic extraction of en-
terally delivered glucose is uncertain.
However, in a series of experiments de-
signed to determine whether splanchnic
glucose metabolism is altered in people
with type 1 diabetes, we used a dual-
tracer approach to measure splanchnic
extractionofintraduodenallyinfusedglu-
cose.Inaddition,ﬂuxthroughtheuridyl-
diphospho-glucose pool (an index of
hepatic glycogen synthesis) was mea-
sured using the acetaminophen glucuro-
nide method (5) in type 1 diabetic and
nondiabetic subjects. Portal venous hor-
mone concentrations were kept constant
and equal in both groups by using soma-
tostatin and replacement amounts of glu-
cagon. Insulin concentrations were
increased to 550 pmol/l, whereas glu-
cose concentrations were clamped at
8.5 mmol/l by means of a supplemental
intravenous glucose infusion (6).
In this situation, wherein glucose, in-
sulin, and glucagon concentrations in
people with type 1 diabetes are matched
tothoseinhealthycontrolsubjects,initial
splanchnic glucose extraction, uridyl-
diphospho-glucose ﬂux, and total body
glucose disappearance do not differ in di-
abetic and nondiabetic subjects during
enteral glucose administration. These
data imply that relative insulin deﬁciency
and/orglucagonexcess,ratherthananin-
trinsic defect in splanchnic glucose me-
tabolism, are the primary causes of
postprandial hyperglycemia in people
withpoorlycontrolledtype1diabetes.Of
noteisthefactthatinsulinconcentrations
were far higher than those present in the
current study.
Basal-bolusinsulinregimenshavebe-
come the cornerstone of therapy for peo-
plewithtype1diabetesinpartbecauseof
their effectiveness in mimicking normal
postprandial insulin secretion, and
thereby achieving good glycemic control,
while avoiding the hypoglycemia that in-
evitablyaccompaniedsimplerinsulinreg-
imens (7). The pattern of postprandial
insulin secretion and the prevailing de-
gree of insulin action (deﬁned as the abil-
ity of insulin to stimulate glucose uptake
and suppress endogenous glucose pro-
duction)interacttoalterpostprandialgly-
cemic excursion (8). Similar to what is
observed in the current study, an appro-
priateriseinpostprandialinsulinconcen-
trations led to higher peak glucose
concentrations and increased glycemic
excursion. To a certain extent, these dif-
ferences were attributable to increased
suppression of endogenous glucose pro-
duction (as observed in the study by Pen-
nant et al. when an insulin bolus was
administered preprandially), at least over
the ﬁrst 180 min after meal ingestion (2).
Absence of meal-induced suppres-
sion of glucagon secretion is also a poten-
tial contributor to postprandial glucose
concentrations in situations wherein the
postprandial rise in insulin is delayed and
decreasedorabsent(9).Unfortunately,in
the current study we are unable to deter-
mine if glucagon concentrations differed
between study days and perhaps con-
tributed to the observed differences in
postprandial glucose concentrations.
Another consideration when examin-
ing the systemic appearance of meal-
derived glucose is the methodology used
to measure this parameter. The dual-
isotope method pioneered by Steele et al.
(10) enabled simultaneous measurement
of both the systemic rate of appearance of
ingested glucose (Ra meal) and postpran-
dial endogenous glucose production.
This method utilizes an infused and an
ingested tracer to trace glucose ﬂuxes.
The appearance of ingested glucose is cal-
culated by multiplying the rate of appear-
ance of the ingested tracer by the tracer-
to-tracee ratio of the ingested meal. Initial
splanchnic glucose uptake can be calcu-
lated by subtracting the portion of the in-
gestedglucosethatreachesthecirculation
fromthetotalamountofglucoseingested.
Endogenous glucose production is calcu-
lated by subtracting Ra meal from the total
glucoseappearance.Althoughthemodel-
calculated appearance of glucose is reli-
ableinasteadystate,itisinaccuratewhen
the ratio of tracer to tracee changes from
inﬁnity during the ﬁrst 15–30 min after
meal ingestion.
This experimental approach has been
used by a large number of investigators to
studypostprandialglucosemetabolismin
awidevarietyofspecies.However,results
havebeeninconsistent.Estimatesofini-
tial splanchnic glucose uptake made by
this method have varied widely, as has
the pattern of endogenous glucose pro-
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near-complete suppression to an initial
paradoxical rise followed by a subse-
quent fall in endogenous glucose pro-
duction (11). These discrepancies are
likely to arise from inadequacies of the
model used to calculate turnover in the
rapidly changing conditions occurring
after carbohydrate ingestion.
In an effort to overcome the marked
changes in the ratio of glucose to tracer
concentrations that occur after meal in-
gestion, we developed and validated a
novel triple-tracer approach to minimize
changes in both meal and endogenous
plasma tracer-to-tracee ratios, thereby al-
lowing simultaneous measurement of Ra
meal and endogenous glucose production.
We minimized changes in plasma ratios
ofinfusedandingestedtracersbyinfusing
[6-
3H]-glucoseinamanneranticipatedto
mimic the systemic Ra of the [1-
13C]-
glucose contained in a mixed meal. At the
sametime,[6,6-
2H2]-glucosewasinfused
inapatternthatmimickedtheanticipated
pattern of change of endogenous glucose
production after meal ingestion (12).
This approach is virtually model in-
dependent, yielding essentially the same
results when interpreted using steady
state or nonsteady state assumptions and
either a one- or two-compartment model
(13).AsemphasizedbyPennantetal.(2),
in comparison, a dual-tracer approach
underestimates systemic glucose appear-
ance by 16%. This systematic under-
estimation of meal glucose appearance
may potentially miss a small effect of
prandial insulin on Ra meal. Another con-
sideration when designing experiments is
the sample size necessary to detect a sig-
niﬁcant change in Ra meal. Given the de-
gree of variance in Ra meal observed in this
experiment and, indeed, in other experi-
ments using a triple-tracer design (14),
eight subjects would be too small a sam-
ple size to reliably detect a 20% change in
Ra meal, let alone a subtler magnitude of
change produced by prandial insulin.
When analyzing the results of this
study, it is important to keep sight of the
fact that prandial insulin administration
dramatically decreases postprandial gly-
cemic excursion. Although this study
does not completely exclude the possibil-
ity that a basal-bolus insulin regimen im-
proves postprandial glycemic control in
partbyalteringRa mealasaconsequenceof
increased splanchnic extraction of meal-
derived glucose, it reemphasizes the im-
portance of suppression of endogenous
glucose production in decreasing post-
prandial glucose concentrations.
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